• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS ANTI-SARS-COV-2; CORONAVIRUS SEROLOGICAL REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS ANTI-SARS-COV-2; CORONAVIRUS SEROLOGICAL REAGENT Back to Search Results
Catalog Number 09203095190
Device Problem False Negative Result (1225)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/21/2020
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).The investigation is ongoing.(b)(6).
 
Event Description
The initial reporter received negative elecsys anti-sars-cov-2 results for one patient tested on a cobas 8000 e 602 module serial number (b)(4).The patient was previously tested with an unknown pcr methodology.The first positive pcr result was performed on (b)(6) 2020.All of the patient samples were tested with menarini covid-19 igg/igm rapid test cassette.Some samples were tested with antibody assays biozek medical covid-19 igg/igm rapid test, innovita 2019-ncov ab test, wondfo sars-cov-2 antibody test, and abbott sars-cov-2 igg assay.The menarini, biozek, innovita, and wondfo antibody assays are not eua approved.
 
Manufacturer Narrative
The customer's calibration and qc data provided were ok.The customer provided the patient's sample for investigation.The investigation confirmed the customer's elecsys anti-sars-cov-2 result, 0.550 non-reactive.The patient's result of 0.550 coi showed a very weak reaction, but it is distinguishable from negative samples ((b)(4) measurements show a coi of 0.2 or less).Tested with creative diagnostics covid19 test igg/igm rapid test, the patient had a reactive igg and igm result.Tested with an independent roche internal research in-house sars-cov2 antibody assay, the patient had a reactive result.Per product labeling, "a negative test result does not rule out the possibility of an infection with sars-cov-2.Serum or plasma samples from the early (pre-seroconversion) phase of illness can yield negative findings.Therefore, this test cannot be used to diagnose an acute infection.Also, over time, titers may decline and eventually become negative." further clarification of the observed discrepancies is not possible with available methods and the current state of the art based on the available data, a general product problem is excluded.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS ANTI-SARS-COV-2
Type of Device
CORONAVIRUS SEROLOGICAL REAGENT
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key10186182
MDR Text Key203508292
Report Number1823260-2020-01521
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 08/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/23/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number09203095190
Device Lot Number496298
Was Device Available for Evaluation? Yes
Date Manufacturer Received05/26/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age86 YR
-
-